These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6197313)

  • 21. Cardiopulmonary pharmacology of enkephalins in the conscious dog.
    Sander GE; Giles TD; Kastin AJ; Quiroz AC; Kaneish A; Coy DH
    Peptides; 1981; 2(4):403-7. PubMed ID: 7329820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand.
    Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ
    J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
    Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB
    Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone reversal of oxymorphone effects in dogs.
    Copland VS; Haskins SC; Patz J
    Am J Vet Res; 1989 Nov; 50(11):1854-8. PubMed ID: 2482683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
    Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
    Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
    [No Abstract]   [Full Text] [Related]  

  • 27. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands.
    Fang X; Larson DL; Portoghese PS
    J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
    Caruso TP; Larson DL; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
    Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
    Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leucine-enkephalin: reversal of intrinsic cardiovascular stimulation by pentobarbital.
    Sander G; Giles T; Kastin A; Kaneish A; Coy D
    Eur J Pharmacol; 1982 Mar; 78(4):467-70. PubMed ID: 7075679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naltrexone-induced opiate receptor supersensitivity.
    Zukin RS; Sugarman JR; Fitz-Syage ML; Gardner EL; Zukin SR; Gintzler AR
    Brain Res; 1982 Aug; 245(2):285-92. PubMed ID: 6289965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of naloxone, naltrexone and morphine in the squirrel monkey.
    Byrd LD
    Life Sci; 1983 Jan; 32(4):391-8. PubMed ID: 6827900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enkephalin analogs and dermorphin in the conscious dog: structure-activity relationships.
    Sander GE; Giles TD
    Peptides; 1982; 3(6):1017-21. PubMed ID: 7167398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of quaternary naloxone on the increased naloxone potency induced by morphine.
    Wong CL; Wai MK
    Clin Exp Pharmacol Physiol; 1984; 11(5):467-71. PubMed ID: 6084569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orientation of the oxygen atom at C-6 as a determinant of agonistic activity in the oxymorphone series.
    Ronai AZ; Foldes FF; Hahn EF; Fishman J
    J Pharmacol Exp Ther; 1977 Mar; 200(3):496-500. PubMed ID: 66306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of leucine-enkephalin with alpha-adrenoceptors in the conscious dog.
    Giles TD; Sander GE
    Chest; 1983 Feb; 83(2 Suppl):364-6. PubMed ID: 6295713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An etorphine-evoked vagal reflex in rats is inhibited by naloxone, N-methylnaloxone, and SMS 201-995.
    Dashwood MR; Kiang JG; Wei ET
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):77-82. PubMed ID: 6198981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioids in the systemic hemodynamic and renal responses to stress in spontaneously hypertensive rats.
    Kapusta DR; Jones SY; DiBona GF
    Hypertension; 1989 Jun; 13(6 Pt 2):808-16. PubMed ID: 2737720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereoselectivity and subtype of the opiate receptor involved in stress-induced hypertension.
    Jiménez I; Iglesias T; Fuentes JA
    Eur J Pharmacol; 1990 Jun; 182(1):155-60. PubMed ID: 2169423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.